<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Jespersen | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/ghostjoin9/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/ghostjoin9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Jespersen.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">ab21f02c20b4c522c1054282d75464e2</guid>
				<title>Jespersen posted an update: wn reinforcement in low rectal stapled anastomosis in [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42244/</link>
				<pubDate>Sun, 09 Feb 2025 08:33:31 -0800</pubDate>

									<content:encoded><![CDATA[<p>wn reinforcement in low rectal stapled anastomosis in preventing anastomotic leak after taTME is safe and feasible.Objective To investigate whether protective colostomy and protective ileostomy have different impact on anastomotic leak for rectal cancer patients after neoadjuvant chemoradiotherapy (nCRT) and radical surgery. Methods A&hellip;<span class="activity-read-more" id="activity-read-more-42244"><a href="http://www.nationalboardinstitute.com/activity/p/42244/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">618fe99f6b935b9f19d10e1569f5a661</guid>
				<title>Jespersen posted an update: Antibodies against the Human Papillomavirus (HPV) L1 protein [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28178/</link>
				<pubDate>Tue, 28 Jan 2025 10:37:16 -0800</pubDate>

									<content:encoded><![CDATA[<p>Antibodies against the Human Papillomavirus (HPV) L1 protein are associated with past infections and related to the evolution of the disease, whereas antibodies against L1 Virus-Like Particles (VLPs) are used to follow the neutralizing antibody response in vaccinated women. In this study, serum antibodies against conformational (VLPs) and linear&hellip;<span class="activity-read-more" id="activity-read-more-28178"><a href="http://www.nationalboardinstitute.com/activity/p/28178/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7ed07a33ac35f4c83068d195028d1b53</guid>
				<title>Jespersen became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28116/</link>
				<pubDate>Tue, 28 Jan 2025 10:33:27 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>